No Cover Image

Journal article 154 views 48 downloads

Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey

Matthew Jones, Amira Guirguis Orcid Logo, Alan Watkins Orcid Logo, Ceri Bradshaw, Lily Mohamed, Fabrizio Schifano

Human Psychopharmacology: Clinical and Experimental, Volume: 38, Issue: 5

Swansea University Authors: Matthew Jones, Amira Guirguis Orcid Logo, Alan Watkins Orcid Logo, Ceri Bradshaw

  • 64608.VOR.pdf

    PDF | Version of Record

    © 2023 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons Ltd. Distributed under the terms of a Creative Commons Attribution 4.0 License (CC BY 4.0).

    Download (259.85KB)

Check full text

DOI (Published version): 10.1002/hup.2882

Abstract

Introduction: Treatment retention is associated with better outcomes and reduced risk amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention remains low amongst this population. Methods: We carried out an international cross-sectional survey of substance use disorde...

Full description

Published in: Human Psychopharmacology: Clinical and Experimental
ISSN: 0885-6222 1099-1077
Published: UK Wiley 2023
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa64608
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: Introduction: Treatment retention is associated with better outcomes and reduced risk amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention remains low amongst this population. Methods: We carried out an international cross-sectional survey of substance use disorder (SUD) treatment service workers. We aimed to understand the barriers to treatment retention in the context of OUD from the provider perspective, identify differences in response preference between professional groups, and describe regional differences in treatment provision. Results: We report data from 497 respondents based in the USA and the UK. Personality disorders, low motivation to change and social problems were the most often reported obstacles to retention. Comorbid SUD, hepatitis and HIV were not reported as often as expected. We identified associations between professional groups and response preferences related to comorbid SUD, low motivation, living arrangements and communication difficulties. UK respondents used behavioural treatments more than their US counterparts. US respondents more often reported using objective methods of measuring retention such as urine analysis, compared to their UK counterparts. Discussion: The findings from this survey suggest that regional differences exist between US and UK based SUD treatment service workers. Personality disorders represented the most often experienced obstacles to treatment retention amongst patients with OUD, with mental health and social problems more often reported than comorbid drug problems or physical health problems. Statistically significant relationships exist between professional group and obstacles reported. These data may be used to identify additional training needs amongst SUD treatment service staff.
Keywords: Addictions, heroin, opioid use disorder, retention, substance use disorder treatment, survey
College: Faculty of Medicine, Health and Life Sciences
Funders: This programme of study was self-funded by the lead author.
Issue: 5